- call +1-201-465-4211
- email sales@mrinsights.biz
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitousdiscovery.
Scope of the Report:
The global Outsourced Drug Discovery market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Outsourced Drug Discovery.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Outsourced Drug Discovery market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Outsourced Drug Discovery market by product type and applications/end industries.
Market Segment by Companies, this report covers
Quintiles
Charles River Laboratories
Aptuit
Evotec
GenScript
PPD
WuXi AppTec
AMRI
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Chemical Services
Biological Services
Lead Optimization
Lead Identification and Screening
Market Segment by Applications, can be divided into
Pharmaceutical Companies
Other
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Outsourced Drug Discovery Market Overview
1.1 Product Overview and Scope of Outsourced Drug Discovery
1.2 Classification of Outsourced Drug Discovery by Types
1.2.1 Global Outsourced Drug Discovery Revenue Comparison by Types (2017-2023)
1.2.2 Global Outsourced Drug Discovery Revenue Market Share by Types in 2017
1.2.3 Chemical Services
1.2.4 Biological Services
1.2.5 Lead Optimization
1.2.6 Lead Identification and Screening
1.3 Global Outsourced Drug Discovery Market by Application
1.3.1 Global Outsourced Drug Discovery Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Pharmaceutical Companies
1.3.3 Other
1.4 Global Outsourced Drug Discovery Market by Regions
1.4.1 Global Outsourced Drug Discovery Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Outsourced Drug Discovery Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Outsourced Drug Discovery Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Outsourced Drug Discovery Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Outsourced Drug Discovery Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Outsourced Drug Discovery Status and Prospect (2013-2023)
1.5 Global Market Size of Outsourced Drug Discovery (2013-2023)
2 Manufacturers Profiles
2.1 Quintiles
2.1.1 Business Overview
2.1.2 Outsourced Drug Discovery Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Quintiles Outsourced Drug Discovery Revenue, Gross Margin and Market Share (2016-2017)
2.2 Charles River Laboratories
2.2.1 Business Overview
2.2.2 Outsourced Drug Discovery Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Charles River Laboratories Outsourced Drug Discovery Revenue, Gross Margin and Market Share (2016-2017)
2.3 Aptuit
2.3.1 Business Overview
2.3.2 Outsourced Drug Discovery Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Aptuit Outsourced Drug Discovery Revenue, Gross Margin and Market Share (2016-2017)
2.4 Evotec
2.4.1 Business Overview
2.4.2 Outsourced Drug Discovery Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Evotec Outsourced Drug Discovery Revenue, Gross Margin and Market Share (2016-2017)
2.5 GenScript
2.5.1 Business Overview
2.5.2 Outsourced Drug Discovery Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GenScript Outsourced Drug Discovery Revenue, Gross Margin and Market Share (2016-2017)
2.6 PPD
2.6.1 Business Overview
2.6.2 Outsourced Drug Discovery Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 PPD Outsourced Drug Discovery Revenue, Gross Margin and Market Share (2016-2017)
2.7 WuXi AppTec
2.7.1 Business Overview
2.7.2 Outsourced Drug Discovery Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 WuXi AppTec Outsourced Drug Discovery Revenue, Gross Margin and Market Share (2016-2017)
2.8 AMRI
2.8.1 Business Overview
2.8.2 Outsourced Drug Discovery Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 AMRI Outsourced Drug Discovery Revenue, Gross Margin and Market Share (2016-2017)
3 Global Outsourced Drug Discovery Market Competition, by Players
3.1 Global Outsourced Drug Discovery Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Outsourced Drug Discovery Players Market Share
3.2.2 Top 10 Outsourced Drug Discovery Players Market Share
3.3 Market Competition Trend
4 Global Outsourced Drug Discovery Market Size by Regions
4.1 Global Outsourced Drug Discovery Revenue and Market Share by Regions
4.2 North America Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
4.3 Europe Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
4.5 South America Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
5 North America Outsourced Drug Discovery Revenue by Countries
5.1 North America Outsourced Drug Discovery Revenue by Countries (2013-2018)
5.2 USA Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
5.3 Canada Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
5.4 Mexico Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
6 Europe Outsourced Drug Discovery Revenue by Countries
6.1 Europe Outsourced Drug Discovery Revenue by Countries (2013-2018)
6.2 Germany Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
6.3 UK Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
6.4 France Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
6.5 Russia Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
6.6 Italy Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Outsourced Drug Discovery Revenue by Countries
7.1 Asia-Pacific Outsourced Drug Discovery Revenue by Countries (2013-2018)
7.2 China Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
7.3 Japan Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
7.4 Korea Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
7.5 India Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
8 South America Outsourced Drug Discovery Revenue by Countries
8.1 South America Outsourced Drug Discovery Revenue by Countries (2013-2018)
8.2 Brazil Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
8.3 Argentina Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
8.4 Colombia Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Outsourced Drug Discovery by Countries
9.1 Middle East and Africa Outsourced Drug Discovery Revenue by Countries (2013-2018)
9.2 Saudi Arabia Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
9.3 UAE Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
9.4 Egypt Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
9.5 Nigeria Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
9.6 South Africa Outsourced Drug Discovery Revenue and Growth Rate (2013-2018)
10 Global Outsourced Drug Discovery Market Segment by Type
10.1 Global Outsourced Drug Discovery Revenue and Market Share by Type (2013-2018)
10.2 Global Outsourced Drug Discovery Market Forecast by Type (2018-2023)
10.3 Chemical Services Revenue Growth Rate (2013-2023)
10.4 Biological Services Revenue Growth Rate (2013-2023)
10.5 Lead Optimization Revenue Growth Rate (2013-2023)
10.6 Lead Identification and Screening Revenue Growth Rate (2013-2023)
11 Global Outsourced Drug Discovery Market Segment by Application
11.1 Global Outsourced Drug Discovery Revenue Market Share by Application (2013-2018)
11.2 Outsourced Drug Discovery Market Forecast by Application (2018-2023)
11.3 Pharmaceutical Companies Revenue Growth (2013-2018)
11.4 Other Revenue Growth (2013-2018)
12 Global Outsourced Drug Discovery Market Size Forecast (2018-2023)
12.1 Global Outsourced Drug Discovery Market Size Forecast (2018-2023)
12.2 Global Outsourced Drug Discovery Market Forecast by Regions (2018-2023)
12.3 North America Outsourced Drug Discovery Revenue Market Forecast (2018-2023)
12.4 Europe Outsourced Drug Discovery Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Outsourced Drug Discovery Revenue Market Forecast (2018-2023)
12.6 South America Outsourced Drug Discovery Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Outsourced Drug Discovery Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Outsourced Drug Discovery Picture
Table Product Specifications of Outsourced Drug Discovery
Table Global Outsourced Drug Discovery and Revenue (Million USD) Market S
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
